Znn3bq.jpeg
²é¿´: 7498  |  »Ø¸´: 18
µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû

zasxcdcd

½ð³æ (СÓÐÃûÆø)

[½»Á÷] ÇëÎÊÒ»ÏÂͶ¸å±»Crosscheck²é³öÀ´31%£¬±à¼­ÒªÇó»ØÓ¦£¬¸ÃÈçºÎÓ¦¶Ô ÒÑÓÐ12È˲ÎÓë

֮ǰͶ¸å1¸öÔ¸ø»Ø´óÐÞ£¬Ð޸ĺ󷵻ر༭£¬ÓÖÁ½¸öÐÇÆÚ·¢À´ÐÅСÐÞ£¬µ«ÊÇÀïÃæ³ýÁËÉó¸åÈ˵ÄÒâ¼ûÖ®Í⻹дÁËÕâÑùÒ»¶Î»°£º
In addition, as you are aware, ACS is screening all manuscripts against the CrossCheck Database. As a result of this process we have received a similarity index greater than 30% for your manuscript. The iThenticate summary report obtained for your manuscript is attached. In particular, there are several statements in your manuscript that are verbatim text from: XXX., et al. Advanced Drug Delivery Reviews 20XX, XX, XX

Ö®ºó²é¿´Á˸½¼þÀïÃæÐ´ÁËSimilarity Index £º31%
¿´ÁËһϣ¬±à¼­Ìáµ½µÄÄÇÆªÓÐ5%£¬¶¼ÊÇÔÚintroductionµÄ±³¾°½éÉÜÀïÃæ
ʣϵÄÈô¸É¶¼ÊÇ<1%µÄ Óкö඼ÊÇʲôÊÔ¼ÁÃû³Æ»òÕßÒÇÆ÷Ãû³ÆµÄ°¡£¬±ÈÈç"1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC, Sigma,  USA)  and N-Hydroxysuccinimide (NHS, Sigma,  USA)"ÓÖ»òÕßÊÇ"Samples were measured by dynamic light scattering with a Zetasizer Nano ZS90 (Malvern Instruments Ltd, Malvern, UK)"£¬
»¹ÓÐһЩ·½·¨Ñ§µÄ²¿·Ö£¬Ò»Ð©ÖîÈçHPLCµÄÁ÷ËÙÒÔ¼°¼ì²â²¨³¤¡£¡£¡£ºÜÎÞÓï
ÁíÍ⻹ÓÐһЩ¾ÍÈÃÎÒ¿ÞЦ²»µÃÁË£¬°üÀ¨" Statistical analysis was performed using Student's T-test or  one  -way analysis of variance (ANOVA) test"ÕâÑùµÄ¾ä×Ó£¬ÒÔ¼°ÔÚͼ±íÏ·½µÄ¡°Data were  expressed  as Mean  ¡À S.D. , *P<0.05 vs CON group, #P<0.05 vs XXX  group¡±£¬ÕâÑùµÄÒ²»á±»ÈÏÎªÖØ¸´³­Ï®²¿·Ö¡£
ÇëÎʸ÷λ³æÓÑÕâÖÖÇé¿öÓ¦¸ÃÔõÑùÐÞ¸ÄÄØ£¬ÎÒÊÇÖ÷ÒªÐÞ¸ÄÒ»ÏÂÇ°ÃæµÄ5%µÄ²¿·Ö£¬»¹ÊÇ˵ËùÓвé³öÀ´µÄ²¿·Ö¶¼ÒªÐÞ¸ÄÄØ£¬È»ºó»Ø¸ø±à¼­ÓÖÒªÔõÑù˵Ã÷ÄØ£¬»á²»»áÖ±½Ó¾Í±»±ÐµôÁË ¡£¡£¡£Ð»Ð»¸÷λ³æÓÑÁË£¡
»Ø¸´´ËÂ¥

» ²ÂÄãϲ»¶

» ±¾Ö÷ÌâÏà¹ØÉ̼ÒÍÆ¼ö: (ÎÒÒ²ÒªÔÚÕâÀïÍÆ¹ã)

ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

Ѧ¶¨ÚÌÁúè

½ð³æ (ÕýʽдÊÖ)

¡ï
Сľ³æ: ½ð±Ò+0.5, ¸ø¸öºì°ü£¬Ð»Ð»»ØÌû
ÇëÎÊÂ¥Ö÷£¬ACS±à¼­¸øÄã·¢µÄÖØ¸´±¨¸æÖлá·ñ°üÀ¨²Î¿¼µÄÖØ¸´£¿
17Â¥2016-05-02 03:15:43
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
²é¿´È«²¿ 19 ¸ö»Ø´ð

×Ô˽µÄè1988

ÈÙÓþ°æÖ÷ (ÎÄ̳¾«Ó¢)

ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷ÓÅÐã°æÖ÷

¡ï ¡ï
Сľ³æ: ½ð±Ò+0.5, ¸ø¸öºì°ü£¬Ð»Ð»»ØÌû
book2005593: ½ð±Ò+1, ¹ÄÀø²ÎÓë½»Á÷~ 2014-11-17 13:52:18
Ö±½Ó˵Ã÷ÕæÊµÇé¿ö£¬²»ÒªÒþÂ÷£¬Ö÷ÒªÊÇÄÄЩµØ·½µÄÖØ¸´Ô­Òò£¬Ò»Ð©ÄÜÐ޸ĵĵط½ÐÞ¸ÄÒ»ÏÂ
2Â¥2014-11-17 10:12:31
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

zasxcdcd

½ð³æ (СÓÐÃûÆø)

ÒýÓûØÌû:
2Â¥: Originally posted by ×Ô˽µÄè1988 at 2014-11-17 10:12:31
Ö±½Ó˵Ã÷ÕæÊµÇé¿ö£¬²»ÒªÒþÂ÷£¬Ö÷ÒªÊÇÄÄЩµØ·½µÄÖØ¸´Ô­Òò£¬Ò»Ð©ÄÜÐ޸ĵĵط½ÐÞ¸ÄÒ»ÏÂ

ÕâÖÖÇé¿ö±»¾ÜµÄ¿ÉÄÜÓжà´ó¡£¡£¡£
3Â¥2014-11-17 11:01:26
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

klmopq

ľ³æ (СÓÐÃûÆø)

¡ï ¡ï ¡ï
Сľ³æ: ½ð±Ò+0.5, ¸ø¸öºì°ü£¬Ð»Ð»»ØÌû
book2005593: ½ð±Ò+2, ¹ÄÀø½»Á÷~ 2014-11-17 13:52:39
Сľ³æ: ½ð±Ò+2, Ìû×ÓÕæ¾«²Ê 2014-11-23 16:25:33
ÎҵĻظ´
Dear Prof¡¤¡¤¡¤¡¤¡¤,

We would like to express our sincere apologies to have so many overlapped descriptions in our manuscript, and we also really appreciate that you give us the opportunity to make explanation. We have provided the explanations in the following paragraph and revised the manuscript to avoid overlapped sentences with our previous papers. The revised parts have been highlighted in the submitted manuscript.

Firstly, we would like to emphasize that this work is novel and different from our previous work and literature reports, which has been demonstrated by the positive comments from peer-reviewers. We also believed it has significant scientific impacts to be published in JPCC. For the overlapped descriptions, our reasons are as followed.

1.        The major overlapped descriptions are in the experimental parts. ¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤
2.        Another major overlapped parts are the affiliation and acknowledgment which is the same as our previous published paper¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤. This is inevitable, because we are still working in the same university and supported by the same funding programs.
3.        The others overlapped parts are minor, and mainly on the technical languages, such as ¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤
4.        The fixed phrases of physical symbol annotations were overlapped, for example, ¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤¡¤
¸øÂú·ÖÎÒ°É£¡£¡£¡
4Â¥2014-11-17 11:15:41
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] 085500Çóµ÷¼Á²ÄÁÏ +5 Ò×11122 2026-04-09 5/250 2026-04-09 21:24 by bljnqdcc
[¿¼ÑÐ] 266Çóµ÷¼Á£¬Ò»Ö¾Ô¸¹þ¹¤³Ìµç×ÓÐÅÏ¢£¬±¾¿Æ»ñ¶àÏî¹ú½±ºÍÊ¡½± +4 lumine1 2026-04-06 4/200 2026-04-09 17:38 by vgtyfty
[¿¼ÑÐ] ²ÄÁϹ¤³Ì085601£¬270Çóµ÷¼Á +26 @ASDF1234 2026-04-08 28/1400 2026-04-09 15:47 by wp06
[¿¼ÑÐ] 070300»¯Ñ§Ñ§Ë¶311·ÖÇóµ÷¼Á +18 Áº¸»¹óÏÕÖÐÇó 2026-04-04 20/1000 2026-04-09 11:18 by ßÕßÕßÕßÉßÉßÉ
[¿¼ÑÐ] 0860004 Çóµ÷¼Á 309·Ö +6 Yin DY 2026-04-09 6/300 2026-04-09 10:19 by °¡Àî999
[¿¼ÑÐ] Ò»Ö¾Ô¸211£¬0703»¯Ñ§305·ÖÇóµ÷¼Á +20 ÑÏÎ÷Î÷Ï· 2026-04-06 26/1300 2026-04-08 22:12 by ¿­¿­Òª±ä˧
[¿¼ÑÐ] 296Çóµ÷¼Á +3 Íô£¡£¿£¡ 2026-04-08 3/150 2026-04-08 22:00 by zhouyuwinner
[¿¼ÑÐ] 324Çóµ÷¼Á +17 ÏëÉÏѧÇóµ÷ 2026-04-03 17/850 2026-04-08 20:04 by ÎÒ¼õ·Ê1
[¿¼ÑÐ] 0703µ÷¼Á£¬Ò»Ö¾Ô¸Ìì½ò´óѧ319·Ö +23 haaaabcd 2026-04-05 26/1300 2026-04-08 16:19 by luoyongfeng
[¿¼ÑÐ] 281Çóµ÷¼Á +10 Ò¬×ÓÄ¢¹½ 2026-04-06 10/500 2026-04-08 11:43 by zzucheup
[¿¼ÑÐ] 259Çóµ÷¼Á +5 ¾Í°®³ÔÍÁ¶¹Ñ½Ñ½ 2026-04-07 5/250 2026-04-07 22:40 by JourneyLucky
[¿¼ÑÐ] 316Çóµ÷¼Á +4 15318418673 2026-04-07 4/200 2026-04-07 22:12 by hemengdong
[¿¼ÑÐ] 315Çóµ÷¼Á +3 TUZEIQAQ 2026-04-02 3/150 2026-04-07 17:32 by chenp123
[¿¼ÑÐ] ²ÄÁϵ÷¼Á +11 Ò»ÑùYWY 2026-04-07 11/550 2026-04-07 15:13 by shdgaomin
[¿¼ÑÐ] 319·Ö085702°²È«¹¤³ÌÇóµ÷¼Á +6 rious 2026-04-05 6/300 2026-04-07 09:42 by jp9609
[¿¼ÑÐ] Çóµ÷¼Áµ½0856²ÄÁϹ¤³Ì +3 ³Ì9915 2026-04-05 3/150 2026-04-05 18:15 by À¶ÔÆË¼Óê
[¿¼ÑÐ] 08ר˶275µ÷¼Á +5 AaAa7420 2026-04-05 5/250 2026-04-05 18:01 by jkddd
[¿¼ÑÐ] Ò»Ö¾Ô¸Î÷±±Å©ÁÖÐóÄÁר˶336·ÖÇóµ÷¼Á +3 5ourr 2026-04-03 3/150 2026-04-05 10:40 by JOKER0401
[¿¼ÑÐ] Äܶ¯µ÷¼Á326ר˶ +4 wan112233 2026-04-04 4/200 2026-04-04 22:47 by yu221
[¿¼ÑÐ] 320Çóµ÷¼Á +3 ũҵ¹¤³ÌÓëÐÅÏ¢¼ 2026-04-03 3/150 2026-04-03 11:40 by ÍÁľ˶ʿÕÐÉú
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û